At this time, posts about Hanmi Pharm are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net sold 9,000 shares today. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.
As of 11:30 AM on the 2nd, Hanmi Pharm's stock price is 308,500 KRW, up 1.31% from the previous day, with a trading volume of 107,323 shares, which is 95.13% of the 5-day average trading volume.
In addition to Hanmi Pharm, posts by investors are also surging for Samsung Life Insurance (032830), UbioLogics (206650), and East Asia Holdings (900110).
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
